PT  - JOURNAL ARTICLE
AU  - Michael Lingzhi Li
AU  - Hamza Tazi Bouardi
AU  - Omar Skali Lami
AU  - Thomas A. Trikalinos
AU  - Nikolaos K. Trichakis
AU  - Dimitris Bertsimas
TI  - Forecasting COVID-19 and Analyzing the Effect of Government Interventions
AID  - 10.1101/2020.06.23.20138693
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.06.23.20138693
4099  - http://medrxiv.org/content/early/2021/06/27/2020.06.23.20138693.short
4100  - http://medrxiv.org/content/early/2021/06/27/2020.06.23.20138693.full
AB  - One key question in the ongoing COVID-19 pandemic is understanding the impact of government interventions, and when society can return to normal. To this end, we develop DELPHI, a novel epidemiological model that captures the effect of under-detection and government intervention. We applied DELPHI across 167 geographical areas since early April, and recorded 6% and 11% two-week out-of-sample Median Absolute Percentage Error on cases and deaths respectively. Furthermore, DELPHI successfully predicted the large-scale epidemics in many areas months before, including US, UK and Russia. Using our flexible formulation of government intervention in DELPHI, we are able to understand how government interventions impacted the pandemic’s spread. In particular, DELPHI predicts that in absence of any interventions, over 14 million individuals would have perished by May 17th, while 280,000 current deaths could have been avoided if interventions around the world started one week earlier. Furthermore, we find mass gathering restrictions and school closings on average reduced infection rates the most, at 29.9 ± 6.9% and 17.3 ± 6.7%, respectively. The most stringent policy, stay-at-home, on average reduced the infection rate by 74.4 ± 3.7% from baseline across countries that implemented it. We also illustrate how DELPHI can be extended to provide insights on reopening societies under different policies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo Funding Sources.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this paper is available at the DELPHI repository hosted on github. https://github.com/CSSEGISandData/COVID-19 https://covid19.healthdata.org/united-states-of-america https://www.bsg.ox.ac.uk/research/research-projects/coronavirus-government-response-tracker https://github.com/COVIDAnalytics/DELPHI